<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>GLP-FAQ</title>
    <link>https://glp-faq.com</link>
    <description>Your one-stop guide to GLP-1 peptides — news, dosing tools, and plain-English answers to the questions everyone is actually asking.</description>
    <language>en-us</language>
    <atom:link href="https://glp-faq.com/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Why Your GLP-1 Weight Loss Plateaued (And What to Try)</title>
      <link>https://glp-faq.com/blog/glp-1-weight-loss-plateau</link>
      <guid>https://glp-faq.com/blog/glp-1-weight-loss-plateau</guid>
      <pubDate>Wed, 06 May 2026 00:00:00 GMT</pubDate>
      <description>Plateaus on Ozempic, Wegovy, or Zepbound are normal — and almost always solvable. Here&apos;s what causes them and the playbook that actually works.</description>
    </item>
    <item>
      <title>What to Eat on GLP-1s When You Have No Appetite</title>
      <link>https://glp-faq.com/blog/what-to-eat-on-glp-1-no-appetite</link>
      <guid>https://glp-faq.com/blog/what-to-eat-on-glp-1-no-appetite</guid>
      <pubDate>Wed, 06 May 2026 00:00:00 GMT</pubDate>
      <description>Your appetite is gone but your body still needs protein, fiber, and nutrients. The eating playbook for Ozempic, Wegovy, and Zepbound users.</description>
    </item>
    <item>
      <title>FDA Posts Liver Failure Report Linked to Lilly&apos;s Foundayo</title>
      <link>https://glp-faq.com/news/foundayo-fda-liver-failure-report-2026-05-06</link>
      <guid>https://glp-faq.com/news/foundayo-fda-liver-failure-report-2026-05-06</guid>
      <pubDate>Wed, 06 May 2026 00:00:00 GMT</pubDate>
      <description>A single liver failure case in the FDA adverse event database briefly knocked Lilly stock; analysts and Lilly say one report is not a safety signal.</description>
    </item>
    <item>
      <title>Mounjaro Dethrones Keytruda as World&apos;s Top-Selling Drug</title>
      <link>https://glp-faq.com/news/mounjaro-overtakes-keytruda-top-selling-drug-2026-05-06</link>
      <guid>https://glp-faq.com/news/mounjaro-overtakes-keytruda-top-selling-drug-2026-05-06</guid>
      <pubDate>Wed, 06 May 2026 00:00:00 GMT</pubDate>
      <description>Eli Lilly&apos;s tirzepatide franchise pulled in $36.5B in 2025, edging past Merck&apos;s Keytruda — the first time a GLP-1 has held the global No. 1 sales spot.</description>
    </item>
    <item>
      <title>Wegovy Pill&apos;s Q1 Sales Double Estimates, Novo Hikes Guidance</title>
      <link>https://glp-faq.com/news/wegovy-pill-q1-launch-doubles-estimates-2026-05-06</link>
      <guid>https://glp-faq.com/news/wegovy-pill-q1-launch-doubles-estimates-2026-05-06</guid>
      <pubDate>Wed, 06 May 2026 00:00:00 GMT</pubDate>
      <description>Novo Nordisk&apos;s oral Wegovy pulled in $354M in its first full quarter — twice analyst forecasts — and the company raised full-year guidance on the strength.</description>
    </item>
    <item>
      <title>Can you get pregnant while taking a GLP-1?</title>
      <link>https://glp-faq.com/faq/glp-1-pregnancy</link>
      <guid>https://glp-faq.com/faq/glp-1-pregnancy</guid>
      <pubDate>Wed, 06 May 2026 00:00:00 GMT</pubDate>
      <description>GLP-1 use during pregnancy isn&apos;t recommended. Manufacturers advise stopping at least 2 months before conception. Surprise pregnancies on these drugs are real.</description>
    </item>
    <item>
      <title>How long can semaglutide stay out of the refrigerator?</title>
      <link>https://glp-faq.com/faq/how-long-can-semaglutide-stay-out-of-fridge</link>
      <guid>https://glp-faq.com/faq/how-long-can-semaglutide-stay-out-of-fridge</guid>
      <pubDate>Wed, 06 May 2026 00:00:00 GMT</pubDate>
      <description>Once in use, an Ozempic or Wegovy pen is good for 56 days at room temperature (under 86°F). Unused pens must stay refrigerated. The full storage rules.</description>
    </item>
    <item>
      <title>What Are GLP-1 Peptides? A Plain-English Guide</title>
      <link>https://glp-faq.com/blog/what-are-glp-1-peptides</link>
      <guid>https://glp-faq.com/blog/what-are-glp-1-peptides</guid>
      <pubDate>Tue, 28 Apr 2026 00:00:00 GMT</pubDate>
      <description>GLP-1 peptides like semaglutide and tirzepatide are reshaping weight loss and metabolic health. What they are, how they work, and what to know before starting.</description>
    </item>
    <item>
      <title>Retatrutide Phase 3: 24% Weight Loss in TRIUMPH-3</title>
      <link>https://glp-faq.com/news/retatrutide-phase-3-readout</link>
      <guid>https://glp-faq.com/news/retatrutide-phase-3-readout</guid>
      <pubDate>Wed, 22 Apr 2026 00:00:00 GMT</pubDate>
      <description>Eli Lilly&apos;s triple-agonist retatrutide hit primary endpoints in TRIUMPH-3 — highest dose group lost nearly a quarter of body weight in under a year.</description>
    </item>
    <item>
      <title>How do I titrate semaglutide?</title>
      <link>https://glp-faq.com/faq/how-do-i-titrate-semaglutide</link>
      <guid>https://glp-faq.com/faq/how-do-i-titrate-semaglutide</guid>
      <pubDate>Sat, 18 Apr 2026 00:00:00 GMT</pubDate>
      <description>The standard semaglutide titration schedule starts at 0.25 mg weekly and increases every 4 weeks. Here&apos;s why the ramp matters and what to do if side effects derail you.</description>
    </item>
  </channel>
</rss>